metaclazepam has been researched along with bromazepam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Marano, P; Nicoletti, F; Patti, F | 1 |
| Bilone, F; Roncari, R | 1 |
2 trial(s) available for metaclazepam and bromazepam
| Article | Year |
|---|---|
Controlled study on the anxiolytic activity of a newly-developed benzodiazepine, metaclazepam.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation | 1988 |
A double-blind comparison of the anxiolytic activity of two benzodiazepines, metaclazepam and bromazepam, in anxiety neurosis.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Bromazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation | 1988 |
1 other study(ies) available for metaclazepam and bromazepam
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |